Based on the key indicators related to Surgery Partners' liquidity, profitability, solvency, and operating efficiency, Surgery Partners is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March. At this time, Surgery Partners' Current Deferred Revenue is fairly stable compared to the past year. Long Term Investments is likely to rise to about 222.3 M in 2025, whereas Total Assets are likely to drop slightly above 4.6 B in 2025. Key indicators impacting Surgery Partners' financial strength include:
The essential information of the day-to-day investment outlook for Surgery Partners includes many different criteria found on its balance sheet. An individual investor should monitor Surgery Partners' cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Surgery Partners.
Please note, the imprecision that can be found in Surgery Partners' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Surgery Partners. Check Surgery Partners' Beneish M Score to see the likelihood of Surgery Partners' management manipulating its earnings.
Surgery Partners Stock Summary
Surgery Partners competes with Pennant, Ensign, Encompass Health, Healthcare Services, and Enhabit. Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee. Surgery Partners operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 8300 people.
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
Cash flow analysis captures how much money flows into and out of Surgery Partners. It measures of how well Surgery is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Surgery Partners brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Surgery had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Surgery Partners has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
Comparative valuation techniques use various fundamental indicators to help in determining Surgery Partners's current stock value. Our valuation model uses many indicators to compare Surgery Partners value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Surgery Partners competition to find correlations between indicators driving Surgery Partners's intrinsic value. More Info.
Surgery Partners is rated fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 1.27 of Return On Asset per Return On Equity. At this time, Surgery Partners' Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Surgery Partners' earnings, one of the primary drivers of an investment's value.
Surgery Partners Systematic Risk
Surgery Partners' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Surgery Partners volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Surgery Partners correlated with the market. If Beta is less than 0 Surgery Partners generally moves in the opposite direction as compared to the market. If Surgery Partners Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Surgery Partners is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Surgery Partners is generally in the same direction as the market. If Beta > 1 Surgery Partners moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Surgery Partners Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Surgery Partners' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Surgery Partners growth as a starting point in their analysis.
Surgery Partners February 27, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Surgery Partners help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Surgery Partners. We use our internally-developed statistical techniques to arrive at the intrinsic value of Surgery Partners based on widely used predictive technical indicators. In general, we focus on analyzing Surgery Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Surgery Partners's daily price indicators and compare them against related drivers.
When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.